IP Library Granted Patent US 9,388,131
Granted Patent B2
US 9,388,131 · App. 14/692,088 · Granted Jul 12, 2016

Automated synthesis of small molecules using chiral, non-racemic boronates

Inventors: Martin D. Burke (Champaign, IL); Junqi Li (Champaign, IL); Eric P. Gillis (Wallingford, CT)
Assignee: The Board of Trustees of the University of Illinois
C07D207/44C07C227/32C07C229/24C07F5/025C07C2101/08C07C2101/14C07C2102/42
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,388,131
App. No.
14/692,088
Granted
Jul 12, 2016
Kind
B2
Abstract

Provided are methods for making and using chiral, non-racemic protected organoboronic acids, including pinene-derived iminodiacetic acid (PIDA) boronates, to direct and enable stereoselective synthesis of organic molecules. Also provided are methods for purifying PIDA boronates from solution. Also provided are methods for deprotection of boronic acids from their PIDA ligands. The purification and deprotection methods may be used in conjunction with methods for coupling or otherwise reacting boronic acids. Iterative cycles of deprotection, coupling, and purification can be performed to synthesize chiral, non-racemic compounds. The methods are suitable for use in an automated chemical synthesis process. Also provided is an automated small molecule synthesizer apparatus for performing automated stereoselective synthesis of chiral, non-racemic small molecules using iterative cycles of deprotection, coupling, and purification.

Claims (71)

1. A compound of formula (II):

wherein:

B is a boron atom having sp 3 hybridization;

the carbon atom marked “*” is a chiral carbon atom of at least 90% enantiomeric excess;

R 10 is selected from the group consisting of

R 11 and each instance of R 12 are independently selected from the group consisting of hydrogen, halogen, hydroxyl, (C1-C10)alkyl, cycloalkyl, aryl, aralkyl, heteroaralkyl, alkoxyl, acyl, acyloxy, aryloxy, amino, and trialkylsilyloxy; or R 11 and any one instance of R 12 , or any two instances of R 12 , taken together, form a 3-10-membered ring;

X is halogen;

each instance of Z is independently selected from the group consisting of CH and N, provided that no more than two instances of Z are N;

X′ is selected from the group consisting of CR 5 R 6 , O, S, and NR 7 ;

R 1 and R 2 are both hydrogen or identically selected (C1-C3)alkyl;

R 5 and R 6 are independently selected from the group consisting of hydrogen, halogen, hydroxyl, (C1-C10)alkyl, cycloalkyl, aryl, aralkyl, heteroaralkyl, alkoxyl, acyl, acyloxy, aryloxy, amino, and trialkylsilyloxy;

R 7 and R 30 are independently selected from the group consisting of hydrogen and (C1-C3)alkyl;

n is 0, 1, or 2;

p is 0, 1, or 2; and

q is 1 or 2.

2. The compound of claim 1 , wherein the compound of formula (II) is

3. The compound of claim 1 , wherein n is 0.

4. The compound of claim 2 , wherein p is 0.

5. The compound of claim 1 , wherein R 10 is

n is 0, p is 0, each instance of R 12 is hydrogen, and R 11 is selected from the group consisting of aryl and methyl.

6. The compound of claim 1 , wherein R 10 is

n is 0, X′ is CH 2 , and R 11 is methyl.

7. The compound claim 1 , wherein R 10 is

8. The compound of claim 1 , wherein R 10 is

9. The compound of claim 1 , wherein R* is a chiral group of at least 95% enantiomeric excess.

10. A method of forming a compound of formula (II)

comprising reacting a compound represented by formula (IV)

with a compound of formula (V)

R 10 —B(OH) 2   (V),

wherein:

B in formula (II) is a boron atom having sp 3 hybridization;

the carbon atom marked “*” is a chiral carbon atom of at least 90% enantiomeric excess;

R 10 is selected from the group consisting of

R 11 and each instance of R 12 are independently selected from the group consisting of hydrogen, halogen, hydroxyl, (C1-C10)alkyl, cycloalkyl, aryl, aralkyl, heteroaralkyl, alkoxyl, acyl, acyloxy, aryloxy, amino, and trialkylsilyloxy; or R 11 and any one instance of R 12 , or any two instances of R 12 , taken together, form a 3-10-membered ring;

X is halogen;

each instance of Z is independently selected from the group consisting of CH and N, provided that no more than two instances of Z are N;

X′ is selected from the group consisting of CR 5 R 6 , O, S, and NR 7 ;

R 1 and R 2 are both hydrogen or identically selected (C1-C3)alkyl;

R 5 and R 6 are independently selected from the group consisting of hydrogen, halogen, hydroxyl, (C1-C10)alkyl, cycloalkyl, aryl, aralkyl, heteroaralkyl, alkoxyl, acyl, acyloxy, aryloxy, amino, and trialkylsilyloxy;

R 7 and R 30 are independently selected from the group consisting of hydrogen and (C1-C3)alkyl;

n is 0, 1, or 2;

p is 0, 1, or 2; and

q is 1 or 2.

11. The method of claim 10 , wherein the compound of formula (II) is

12. A method of performing a stereoselective chemical reaction, comprising:

contacting a compound of formula (II) with a reagent

wherein:

R 10 is chemically transformed in a stereoselective manner;

the carbon atom marked “*” is a chiral carbon atom of at least 90% enantiomeric excess;

B is a boron atom having sp 3 hybridization;

R 10 is selected from the group consisting of

R 11 and each instance of R 12 are independently selected from the group consisting of hydrogen, halogen, hydroxyl, (C1-C10)alkyl, cycloalkyl, aryl, aralkyl, heteroaralkyl, alkoxyl, acyl, acyloxy, aryloxy, amino, and trialkylsilyloxy; or R 11 and any one instance of R 12 , or any two instances of R 12 , taken together, form a 3-10-membered ring;

X is halogen;

each instance of Z is independently selected from the group consisting of CH and N, provided that no more than two instances of Z are N;

X′ is selected from the group consisting of CR 5 R 6 , O, S, and NR 7 ;

R 1 and R 2 are both hydrogen or identically selected (C1-C3)alkyl;

R 5 and R 6 are independently selected from the group consisting of hydrogen, halogen, hydroxyl, (C1-C10)alkyl, cycloalkyl, aryl, aralkyl, heteroaralkyl, alkoxyl, acyl, acyloxy, aryloxy, amino, and trialkylsilyloxy;

R 7 and R 30 are independently selected from the group consisting of hydrogen and (C1-C3)alkyl;

n is 0, 1, or 2;

p is 0, 1, or 2; and

q is 1 or 2.

13. The method of claim 12 , wherein the compound of formula (II) is

14. The method of claim 12 , wherein R 10 is

n is 0, p is 0, each instance of R 12 is hydrogen, and R 11 is selected from the group consisting of aryl and methyl.

15. The method of claim 12 , wherein R 10 is

n is 0, X′ is CH 2 , and R 11 is methyl.

16. The method of claim 12 , wherein R 10 is

17. The method of claim 12 , wherein R 10 is

18. The method of claim 12 , wherein the reagent is selected from the group consisting of oxidants, nucleophiles, bases, and electrophiles.

19. The method of claim 12 , wherein the chemical reaction is selected from epoxidation, nucleophilic substitution, electrophilic substitution, oxidation, dihydroxylation, carbonylation, alkenation, cyclopropanation, cycloaddition, conjugate addition, Michael addition, Diels-Alder reaction, and transition metal-catalyzed cross-coupling reaction.

20. The method of claim 12 , wherein the reagent is a chiral reagent.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2015
From: BURKE, MARTIN D.; LI, JUNQI; GILLIS, ERIC P.
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 036043/0316 →
Continuity (4)
Division 14112985
Provisional Application 61590225 · Jan 24, 2012
Provisional Application 61479596 · Apr 27, 2011
Related Publication 20150329567A1 · Nov 19, 2015